Skip to main content
profile image
Selected Works of John M. Pagel, MD, PhD
Article
Updated Efficacy Including Genetic and Clinical Subgroup Analysis and Overall Safety in the Phase 3 RESONATETM Trial of Ibrutinib Versus Ofatumumab in Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Blood (2014)
  • Jennifer R. Brown, Harvard University
  • Peter Hillmen, St James's University Hospital
  • Susan O'Brien, University of Texas MD Anderson Cancer Center
  • Jaqueline C. Barrientos, Hofstra University
  • Nishitha Reddy, Vanderbilt University
  • Steven Coutre, Stanford University
  • Constantine Tam, Peter MacCallum Cancer Centre
  • Stephen Mulligan, Royal North Shore Hospital
  • Ulrich Jaeger, Medical University of Vienna
  • Paul M. Barr, University of Rochester Medical Center
  • Richard R. Furman, NewYork–Presbyterian Hospital
  • Thomas J. Kipps, University of California, San Diego
  • Florence Cymbalista, University of Paris
  • Patrick Thornton, Beaumont Hospital
  • Federico Caligaris-Cappio, Vita-Salute San Raffaele University
  • Julio Delgado, University of Utah
  • Marco Montillo, Catholic University of the Sacred Heart
  • Sven DeVos, University of California, Los Angeles
  • Carol Moreno, Autonomous University of Barcelona
  • John Pagel, Fred Hutchinson Cancer Research Center
  • Jan A. Burger, University of Texas MD Anderson Cancer Center
  • Devon Chung
  • Jennifer Lin, Janssen Pharmaceutica
  • Linda Gau
  • Betty Chang, Millennium Pharmaceuticals
  • Jesse McGreivy
  • Danelle F. James, University of California, San Diego
  • John C. Byrd, Ohio State University
Link
Disciplines
Publication Date
December 6, 2014
Citation Information
Jennifer R. Brown, Peter Hillmen, Susan O'Brien, Jaqueline C. Barrientos, et al.. "Updated Efficacy Including Genetic and Clinical Subgroup Analysis and Overall Safety in the Phase 3 RESONATETM Trial of Ibrutinib Versus Ofatumumab in Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma" Blood Vol. 124 Iss. 21 (2014) p. 3331 - 3331
Available at: http://works.bepress.com/john-pagel/91/